Himalaya Abana regulates serum lipids by lowering the cholesterol, triglyceride, low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) levels, and restores the cardioprotective high-density lipoprotein (HDL) level. Abana also reduces platelet aggregation. Moreover, Abana reduces the sensitivity of the heart to adrenergic stimulation. Abana improves the contractility of the heart by exerting a positive inotropic action. Thus Abana produces cardioprotection. Abana tablets are useful: In hyperlipidemic conditions In mild to moderate hypertension As an adjuvant in the therapy of angina with cardiac risk factors Cardiovascular and cerebrovascular conditions requiring inhibition of platelet aggregation.